Atlanta VA Medical and Rehab Center, Decatur
Decatur, Georgia, 30033, United States
NCT Number: NCT00714571
Memory deficits are common after traumatic brain injuries (TBI) and are characteristic of various forms of dementia, such as Alzheimer's disease and its common precursor mild cognitive impairment (MCI). This project intends to assess the efficacy of cognitive rehabilitation in these patient populations. We will also use neuroimaging (functional magnetic resonance imaging - fMRI) to assess changes in brain activity that occur following cognitive rehabilitation.
Looking for future studies?
Notify Me18 year–88 year
All sexes
Interventional
Phase 1
Decatur, Georgia, 30033, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
General inclusion criteria (all patients):
MCI Inclusion Criteria:
TBI Inclusion criteria:
Exclusion criteria
Time frame: Pre-training, post-training, 1 month
Accuracy (Percent correct) for trained stimuli. Stage 1: Object location association test Stage 2: Face name association test
VA Office of Research and Development
Fed
Behavioral and Neuroimaging Changes After Cognitive Rehab in TBI and MCI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01687153
Alzheimer Disease, Alzheimer's Disease
Sun City, Arizona, United States
View Trial DetailsNCT03233646
APOE-4 Positive, Abnormalities, Multiple
Durham, North Carolina, United States
View Trial DetailsNCT05019014
Alzheimer Disease, Amyotrophic Lateral Sclerosis
Boston, Massachusetts, United States
View Trial DetailsNCT02266563
Alzheimer Disease, Brain Damage, Chronic
New York, United States
View Trial Details